Metronidazole Treatment Failure and Persistent BV Lead to Increased Frequencies of Activated T- and Dendritic-Cell Subsets.

BV treatment genital immune cells vaginal microbiota

Journal

Microorganisms
ISSN: 2076-2607
Titre abrégé: Microorganisms
Pays: Switzerland
ID NLM: 101625893

Informations de publication

Date de publication:
27 Oct 2023
Historique:
received: 21 09 2023
revised: 21 10 2023
accepted: 23 10 2023
medline: 25 11 2023
pubmed: 25 11 2023
entrez: 25 11 2023
Statut: epublish

Résumé

Metronidazole (MDZ) treatment failure and bacterial vaginosis (BV) recurrence rates are high among African women. This cohort study identified genital immune parameters associated with treatment response by comparing vaginal microbiota and immune cell frequencies in endocervical cytobrushes obtained from 32 South African women with symptomatic BV pre- and post-metronidazole treatment. Cervical T- and dendritic-cell subsets were phenotyped using multiparameter flow cytometry and the composition of vaginal microbial communities was characterized using 16S rRNA gene sequencing. MDZ treatment led to a modest decrease in the relative abundance of BV-associated bacteria, but colonization with

Identifiants

pubmed: 38004655
pii: microorganisms11112643
doi: 10.3390/microorganisms11112643
pmc: PMC10673474
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : NIAID NIH HHS
ID : R21 AI116759
Pays : United States

Références

N Engl J Med. 2020 May 14;382(20):1906-1915
pubmed: 32402161
J Immunol. 2011 Dec 1;187(11):6032-42
pubmed: 22048765
Int J Med Microbiol. 2015 Dec;305(8):815-27
pubmed: 26372530
PLoS One. 2009;4(2):e4365
pubmed: 19197385
J Infect Dis. 2016 Aug 15;214 Suppl 1:S14-20
pubmed: 27449869
BMC Microbiol. 2009 Jun 02;9:116
pubmed: 19490622
Microbiology (Reading). 2018 Mar;164(3):349-358
pubmed: 29458690
Nat Immunol. 2010 Aug;11(8):647-55
pubmed: 20644570
PLoS Med. 2008 Apr 1;5(4):e81
pubmed: 18384232
PLoS One. 2013 Apr 09;8(4):e60670
pubmed: 23585843
Am J Obstet Gynecol. 2020 Feb;222(2):157.e1-157.e13
pubmed: 31404542
Appl Environ Microbiol. 2020 Oct 1;86(20):
pubmed: 32801180
Clin Infect Dis. 2013 Mar;56(6):777-86
pubmed: 23243173
Nat Med. 2019 Oct;25(10):1500-1504
pubmed: 31591599
Infect Immun. 2005 Dec;73(12):7967-76
pubmed: 16299289
AIDS Res Hum Retroviruses. 2015 Nov;31(11):1139-52
pubmed: 26204200
Clin Ther. 2008 Mar;30(3):453-68
pubmed: 18405785
J Infect Dis. 2006 Jun 1;193(11):1478-86
pubmed: 16652274
Sex Transm Infect. 2014 Dec;90(8):580-7
pubmed: 25107710
Annu Rev Immunol. 2002;20:621-67
pubmed: 11861614
Anaerobe. 2008 Nov;14(5):256-60
pubmed: 18849004
Clin Vaccine Immunol. 2015 May;22(5):526-38
pubmed: 25761460
Histol Histopathol. 2014 May;29(5):567-87
pubmed: 24327088
Mediators Inflamm. 2010;2010:976024
pubmed: 20396665
Clin Immunol Immunopathol. 1995 Oct;77(1):33-41
pubmed: 7554481
Immunology. 2009 Sep;128(1 Suppl):e746-57
pubmed: 19740336
J Med Microbiol. 2016 May;65(5):377-386
pubmed: 26887782
Immunity. 2017 Jan 17;46(1):29-37
pubmed: 28087240
Curr Top Microbiol Immunol. 2006;311:17-58
pubmed: 17048704
Clin Immunol. 2006 Apr;119(1):51-8
pubmed: 16413828
PLoS One. 2018 Apr 24;13(4):e0196209
pubmed: 29689080
Clin Infect Dis. 2019 May 2;68(10):1675-1683
pubmed: 30407498
PLoS Pathog. 2016 Jul 14;12(7):e1005761
pubmed: 27415008
Microb Pathog. 2020 Apr;141:104029
pubmed: 32014462
Clin Infect Dis. 2015 Jul 15;61(2):260-9
pubmed: 25900168
PLoS One. 2018 Jan 18;13(1):e0191524
pubmed: 29346438
PLoS One. 2016 May 12;11(5):e0155668
pubmed: 27171482
Immunity. 2015 May 19;42(5):965-76
pubmed: 25992865
Nat Med. 2018 May;24(4):491-496
pubmed: 29480895
Sex Transm Infect. 2016 May;92(3):186-93
pubmed: 26511781
Sci Rep. 2020 Apr 10;10(1):6196
pubmed: 32277092
Front Immunol. 2021 Sep 14;12:730986
pubmed: 34594336
Infect Immun. 2017 Dec 19;86(1):
pubmed: 29038128
Microorganisms. 2020 Jun 09;8(6):
pubmed: 32527048
Microbiome. 2020 Nov 23;8(1):166
pubmed: 33228810
Front Physiol. 2015 Mar 25;6:81
pubmed: 25859220
Microbiome. 2021 Jul 26;9(1):163
pubmed: 34311774
Nat Rev Immunol. 2017 Sep;17(9):545-558
pubmed: 28580957
Cell. 2016 May 5;165(4):842-53
pubmed: 27133167
Nat Rev Immunol. 2004 Aug;4(8):648-55
pubmed: 15286731
PLoS One. 2013 Dec 20;8(12):e82599
pubmed: 24376552
Arch Gynecol Obstet. 2015 Mar;291(3):605-9
pubmed: 25245669
Clin Exp Immunol. 2001 Sep;125(3):485-91
pubmed: 11531958

Auteurs

Wenkosi Perez Qulu (WP)

Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban 4001, South Africa.
Department of Medical Microbiology, University of KwaZulu-Natal, Durban 4001, South Africa.

Gugulethu Mzobe (G)

Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban 4001, South Africa.
Department of Medical Microbiology, University of KwaZulu-Natal, Durban 4001, South Africa.

Andile Mtshali (A)

Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban 4001, South Africa.
Department of Medical Microbiology, University of KwaZulu-Natal, Durban 4001, South Africa.

Marothi Peter Letsoalo (MP)

Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban 4001, South Africa.

Farzana Osman (F)

Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban 4001, South Africa.

James Emmanuel San (JE)

KwaZulu-Natal Research Innovation and Sequencing Platform, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban 4001, South Africa.

Asavela Olona Kama (AO)

Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban 4001, South Africa.

Nigel Garrett (N)

Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban 4001, South Africa.
Discipline of Public Health Medicine, University of KwaZulu-Natal, Durban 4001, South Africa.

Adrian Mindel (A)

Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban 4001, South Africa.

Anne Rompalo (A)

Department of Gynecology and Obstetrics, Johns Hopkins University, Baltimore, MD 21287, USA.

Lenine J P Liebenberg (LJP)

Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban 4001, South Africa.
Department of Medical Microbiology, University of KwaZulu-Natal, Durban 4001, South Africa.
Centre for Epidemic Response and Innovation (CERI), Stellenbosch 7600, South Africa.

Derseree Archary (D)

Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban 4001, South Africa.
Department of Medical Microbiology, University of KwaZulu-Natal, Durban 4001, South Africa.

Aida Sivro (A)

Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban 4001, South Africa.
Department of Medical Microbiology, University of KwaZulu-Natal, Durban 4001, South Africa.
JC Wilt Infectious Disease Research Centre, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3L5, Canada.
Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, MB R3E 3L5, Canada.

Sinaye Ngcapu (S)

Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban 4001, South Africa.
Department of Medical Microbiology, University of KwaZulu-Natal, Durban 4001, South Africa.

Classifications MeSH